/ /

  • linkedin
  • Increase Font
  • Sharebar

    Imaging technology advances meibomian gland visualization

    Next-generation tool helps determine lipid deficiency, detect MGD in earliest phases


    The technology is intended to be used with other products from the manufacturer—i.e., its Korb Meibomian Gland Evaluator and LipiFlow treatment for the ocular surface that helps restore meibomian gland function.


    Eric D. Donnenfeld, MD

    E: [email protected]

    Dr. Donnenfeld is a consultant to TearScience. The LipiView II is expected to become commercially available in early 2015 with upgrade options available for owners of the current technology.



    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results